B J Maron

Summary

Affiliation: Minneapolis Heart Institute Foundation
Country: USA

Publications

  1. doi request reprint Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy
    Martin S Maron
    Division of Cardiology, Hypertrophic Cardiomyopathy Center, Tufts Medical Center, Boston, Massachussetts 02111, USA
    Circulation 118:1541-9. 2008
  2. doi request reprint It is not prudent to allow all athletes with implantable-cardioverter defibrillators to participate in all sports
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA
    Heart Rhythm 5:864-6. 2008
  3. ncbi request reprint Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota Electronic address
    J Am Coll Cardiol 64:83-99. 2014
  4. ncbi request reprint Strategies for assessing the prevalence of cardiovascular sudden deaths in young competitive athletes
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, MN, United States Electronic address
    Int J Cardiol 173:369-72. 2014
  5. ncbi request reprint Incidence and causes of sudden death in U.S. college athletes
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota Electronic address
    J Am Coll Cardiol 63:1636-43. 2014
  6. doi request reprint Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, MN 55407, USA
    J Am Coll Cardiol 61:1527-35. 2013
  7. doi request reprint Risk stratification and outcome of patients with hypertrophic cardiomyopathy >=60 years of age
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, 920 E 28th St, Ste 620, Minneapolis, MN 55407, USA
    Circulation 127:585-93. 2013
  8. ncbi request reprint Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, MN, USA
    J Am Coll Cardiol 60:705-15. 2012
  9. ncbi request reprint Hypertrophic cardiomyopathy with longevity to 90 years or older
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minnesota, USA
    Am J Cardiol 109:1341-7. 2012
  10. doi request reprint Double or compound sarcomere mutations in hypertrophic cardiomyopathy: a potential link to sudden death in the absence of conventional risk factors
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota 55407, USA
    Heart Rhythm 9:57-63. 2012

Detail Information

Publications107 found, 100 shown here

  1. doi request reprint Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy
    Martin S Maron
    Division of Cardiology, Hypertrophic Cardiomyopathy Center, Tufts Medical Center, Boston, Massachussetts 02111, USA
    Circulation 118:1541-9. 2008
    ..This study reports the prevalence, morphology, clinical course, and management of an underrecognized subgroup of HCM patients with left ventricular apical aneurysms...
  2. doi request reprint It is not prudent to allow all athletes with implantable-cardioverter defibrillators to participate in all sports
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA
    Heart Rhythm 5:864-6. 2008
  3. ncbi request reprint Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota Electronic address
    J Am Coll Cardiol 64:83-99. 2014
    ....
  4. ncbi request reprint Strategies for assessing the prevalence of cardiovascular sudden deaths in young competitive athletes
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, MN, United States Electronic address
    Int J Cardiol 173:369-72. 2014
    ..Since event reporting is not mandatory, identification of cases has been achieved largely through publicly available data and internet searches. The accuracy of this methodology has not been studied and deserves scrutiny...
  5. ncbi request reprint Incidence and causes of sudden death in U.S. college athletes
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota Electronic address
    J Am Coll Cardiol 63:1636-43. 2014
    ..The goal of this study was to reliably define the incidence and causes of sudden death in college student-athletes...
  6. doi request reprint Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, MN 55407, USA
    J Am Coll Cardiol 61:1527-35. 2013
    ..The aim of this study was to determine the efficacy of implantable cardioverter-defibrillators (ICDs) in children and adolescents with hypertrophic cardiomyopathy (HCM)...
  7. doi request reprint Risk stratification and outcome of patients with hypertrophic cardiomyopathy >=60 years of age
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, 920 E 28th St, Ste 620, Minneapolis, MN 55407, USA
    Circulation 127:585-93. 2013
    ..Whether patients of more advanced age harbor similar risks is unresolved, often creating clinical dilemmas, particularly in decisions for primary prevention of sudden death with implantable defibrillators...
  8. ncbi request reprint Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, MN, USA
    J Am Coll Cardiol 60:705-15. 2012
    ....
  9. ncbi request reprint Hypertrophic cardiomyopathy with longevity to 90 years or older
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minnesota, USA
    Am J Cardiol 109:1341-7. 2012
    ..This principle regarding the natural history of HC can afford a measure of reassurance to many patients...
  10. doi request reprint Double or compound sarcomere mutations in hypertrophic cardiomyopathy: a potential link to sudden death in the absence of conventional risk factors
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota 55407, USA
    Heart Rhythm 9:57-63. 2012
    ..Therefore, additional genetic risk markers that reliably determine which patients are predisposed to sudden death are needed...
  11. ncbi request reprint Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, 920 E 28th St, Ste 620, Minneapolis, MN 55407, USA
    JAMA 301:1253-9. 2009
    ..However, the natural history and phenotypic expression of this newly recognized disease is incompletely resolved and its identification may have important clinical implications...
  12. ncbi request reprint Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation and Abbott Northwestern Hospital, Minneapolis, Minn, USA
    Circulation 119:1085-92. 2009
    ..Sudden deaths in young competitive athletes are highly visible events with substantial impact on the physician and lay communities. However, the magnitude of this public health issue has become a source of controversy...
  13. doi request reprint The first patient clinically diagnosed with hypertrophic cardiomyopathy
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, MN, USA
    Am J Cardiol 102:1418-20. 2008
    ....
  14. doi request reprint Implantable defibrillators and prevention of sudden death in hypertrophic cardiomyopathy
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota 55407, USA
    J Cardiovasc Electrophysiol 19:1118-26. 2008
    ..Therefore, a single marker of high risk may represent sufficient evidence to justify the recommendation for a prophylactic ICD in selected patients with HCM...
  15. ncbi request reprint Sudden cardiac arrest in hypertrophic cardiomyopathy in the absence of conventional criteria for high risk status
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA
    Am J Cardiol 101:544-7. 2008
    ....
  16. ncbi request reprint Hypertrophic cardiomyopathy and other causes of sudden cardiac death in young competitive athletes, with considerations for preparticipation screening and criteria for disqualification
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, MN 55407, USA
    Cardiol Clin 25:399-414, vi. 2007
    ..Removal from intense training and competition is recommended for athletes with HCM, some of whom may ultimately be judged to be at unacceptably high risk for sudden death and eligible for prophylactic defibrillator implantation...
  17. ncbi request reprint Controversies in cardiovascular medicine. Surgical myectomy remains the primary treatment option for severely symptomatic patients with obstructive hypertrophic cardiomyopathy
    Barry J Maron
    Minneapolis Heart Institute Foundation, 920 E 28th St, Ste 60, Minneapolis, MN 55407, USA
    Circulation 116:196-206; discussion 206. 2007
  18. ncbi request reprint Images in cardiovascular medicine. Diagnostic utility of cardiac magnetic resonance imaging in monozygotic twins with hypertrophic cardiomyopathy and identical pattern of left ventricular hypertrophy
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, 920 East 28th Street, Minneapolis, MN 55407, USA
    Circulation 115:e627-8. 2007
  19. ncbi request reprint The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death
    Barry J Maron
    The Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, 920 East 28th St, Suite 60, Minneapolis, MN 55407, USA
    Circulation 114:1633-44. 2006
  20. ncbi request reprint Comparison of U.S. and Italian experiences with sudden cardiac deaths in young competitive athletes and implications for preparticipation screening strategies
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA
    Am J Cardiol 104:276-80. 2009
    ..These data do not support a lower mortality rate associated with preparticipation screening programs involving routine electrocardiography and examinations by specially trained personnel...
  21. ncbi request reprint Historical observation on commotio cordis
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota 55407, USA
    Heart Rhythm 3:605-6. 2006
  22. ncbi request reprint Death in a young athlete due to commotio cordis despite prompt external defibrillation
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota 55407, USA
    Heart Rhythm 2:991-3. 2005
  23. ncbi request reprint Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy
    Barry J Maron
    Hypertrophic Cardiomyopathy Center of the Minneapolis Heart Institute Foundation, Minneapolis, Minnesota 55407, USA
    JAMA 298:405-12. 2007
    ..However, the effectiveness and appropriate selection of patients for this therapy is incompletely resolved...
  24. doi request reprint Circadian patterns in the occurrence of malignant ventricular tachyarrhythmias triggering defibrillator interventions in patients with hypertrophic cardiomyopathy
    Barry J Maron
    Hypertrophic Cardiomyopathy Center of the Minneapolis Heart Institute Foundation, Minneapolis, Minnesota 55407, USA
    Heart Rhythm 6:599-602. 2009
    ..However, little is known about the circadian pattern of life-threatening arrhythmias in HCM in the contemporary era of the implantable cardioverter-defibrillator (ICD)...
  25. ncbi request reprint Long-term survival after cardiac arrest in hypertrophic cardiomyopathy
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota 55407, USA
    Heart Rhythm 6:993-7. 2009
    ..However, outcome over extended time periods after major arrhythmic events is unresolved in such HCM patients...
  26. doi request reprint Onset of apical hypertrophic cardiomyopathy in adulthood
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital, Minnesota, USA
    Am J Cardiol 108:1783-7. 2011
    ..Electrocardiographic repolarization abnormalities can predict the future development of apical LV hypertrophy in adults with HC...
  27. doi request reprint "Speckled" ventricular septum in hypertrophic cardiomyopathy revisited after 30 years
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA
    Am J Cardiol 107:1862-3. 2011
    ..In conclusion, myocardial fibrosis in patients with hypertrophic cardiomyopathy is most reliably identified using contrast-enhanced cardiovascular magnetic resonance imaging...
  28. doi request reprint Controversies in cardiovascular medicine. Benefits of surgery in obstructive hypertrophic cardiomyopathy: bring septal myectomy back for European patients
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, 920 E 28th Street, Minneapolis, MN 55407, USA
    Eur Heart J 32:1055-8. 2011
    ..It is our aspiration that this discussion will generate reconsideration and resurgence of interest in surgical septal myectomy as a treatment option for severely symptomatic obstructive HCM patients within Europe...
  29. ncbi request reprint Risk stratification and role of implantable defibrillators for prevention of sudden death in patients with hypertrophic cardiomyopathy
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, MN 55407, USA
    Circ J 74:2271-82. 2010
    ..Indeed, prevention of SCD has now become a new paradigm in the management of HCM...
  30. doi request reprint Profound left ventricular remodeling associated with LAMP2 cardiomyopathy
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA
    Am J Cardiol 106:1194-6. 2010
    ..e. marked wall thinning), chamber dilatation, and severe systolic dysfunction, all of which are associated with widespread transmural scarring...
  31. doi request reprint Novel hypertrophic cardiomyopathy phenotype: segmental hypertrophy isolated to the posterobasal left ventricular free wall
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minnesota, USA
    Am J Cardiol 106:750-2. 2010
    ....
  32. doi request reprint Sudden death in hypertrophic cardiomyopathy
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, MN, 55407, USA
    J Cardiovasc Transl Res 2:368-80. 2009
    ..Prevention of SD is now an integral, albeit challenging, component of HCM management...
  33. ncbi request reprint Can sudden cardiac death be prevented?
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, MN 55407, USA
    Cardiovasc Pathol 19:329-35. 2010
    ..Indeed, prevention of sudden death has now become an integral, albeit challenging, component of overall hypertrophic cardiomyopathy management...
  34. ncbi request reprint Hypertrophic cardiomyopathy: practical steps for preventing sudden death
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, MN, 55407, USA
    Phys Sportsmed 30:19-24. 2002
    ..Molecular detection methods for known defective genes in HCM have not yet become routine clinical tools. Athletes with unequivocal HCM should not participate in competitive sports, except for perhaps some low-intensity ones...
  35. ncbi request reprint Implications of hypertrophic cardiomyopathy transmitted by sperm donation
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation and Abbott Northwestern Hospital, Minneapolis, Minnesota 55407, USA
    JAMA 302:1681-4. 2009
    ..The unintended consequence in which genetic diseases are unwittingly transmitted to offspring is an underrecognized public health issue not previously prioritized by US Food and Drug Administration guidelines...
  36. ncbi request reprint [Prevention of sudden death in hypertrophic cardiomyopathy (HCM ): implanted defibrillators in HCM]
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, MN 55407, USA
    Zhonghua Xin Xue Guan Bing Za Zhi 37:297-302. 2009
    ..A single marker of high risk can be sufficient evidence to justify the recommendation for a prophylactic ICD in selected patients with HCM...
  37. doi request reprint Distinguishing hypertrophic cardiomyopathy from athlete's heart physiological remodelling: clinical significance, diagnostic strategies and implications for preparticipation screening
    B J Maron
    Minneapolis Heart Institute Foundation, 920 East 28th Street, Suite 620, Minneapolis, MN 55407, USA
    Br J Sports Med 43:649-56. 2009
    ..Consensus criteria and recommendations for eligibility and disqualification of athletes with HCM (and other cardiovascular abnormalities) have proved useful to the practising community...
  38. doi request reprint Commotio cordis and the epidemiology of sudden death in competitive lacrosse
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, MN 55407, USA
    Pediatrics 124:966-71. 2009
    ..Athletic field risks associated with blunt, nonpenetrating chest blows (commotio cordis) are receiving increasing attention, but the epidemiology of these events is incomplete...
  39. doi request reprint The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy: from idiopathic hypertrophic subaortic
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota 55407, USA
    J Am Coll Cardiol 54:191-200. 2009
    ....
  40. ncbi request reprint Ten common questions about hypertrophic cardiomyopathy...and misconceptions
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota 55407, USA
    Cardiol Rev 13:59-60. 2005
  41. ncbi request reprint Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations
    B J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minnesota 55407, USA
    J Am Coll Cardiol 38:315-21. 2001
    ..We sought to determine whether the development of left ventricular hypertrophy (LVH) can be demonstrated during adulthood in genetically affected relatives with hypertrophic cardiomyopathy (HCM)...
  42. pmc Extreme hypertrophic cardiomyopathy
    B J Maron
    Heart 90:24. 2004
  43. ncbi request reprint Hypertrophic cardiomyopathy in childhood
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, 920 East 28th Street, Suite 60, Minneapolis, MN 55407, USA
    Pediatr Clin North Am 51:1305-46. 2004
    ..Consequently, it is timely to place perspective and clarify many of these relevant clinical issues, and profile the rapidly evolving concepts regarding HCM, especially as they may impact on this disease in childhood...
  44. ncbi request reprint Clinical profile and spectrum of commotio cordis
    Barry J Maron
    Minneapolis Heart Institute Foundation, 920 E 28th St, Suite 60, Minneapolis, MN 55407, USA
    JAMA 287:1142-6. 2002
    ..Although blunt, nonpenetrating chest blows causing sudden cardiac death (commotio cordis) are often associated with competitive sports, dangers implicit in such blows can extend into many other life activities...
  45. ncbi request reprint Hypertrophic cardiomyopathy: a systematic review
    Barry J Maron
    Minneapolis Heart Institute Foundation, 920 E 28th St, Suite 60, Minneapolis, MN 55407, USA
    JAMA 287:1308-20. 2002
    ....
  46. ncbi request reprint Prevalence of hypertrophic cardiomyopathy in a population-based sample of American Indians aged 51 to 77 years (the Strong Heart Study)
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota 55407, USA
    Am J Cardiol 93:1510-4. 2004
    ..This prevalence was similar to that reported in other general populations comprised of younger subjects of other races, offering evidence that HC is a relatively common genetic disease with widespread occurrence within the United States...
  47. ncbi request reprint Cardiology patient pages. Hypertrophic cardiomyopathy
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, Minn 55407, USA
    Circulation 106:2419-21. 2002
  48. ncbi request reprint Relation of extreme left ventricular hypertrophy to age in hypertrophic cardiomyopathy
    Barry J Maron
    Minneapolis Heart Institute Foundation, Minneapolis, Minnesota 55407, USA
    Am J Cardiol 91:626-8. 2003
  49. ncbi request reprint Two husbands--one disease: the broad clinical spectrum of hypertrophic cardiomyopathy
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota 55407, USA
    Am J Cardiol 89:899-900. 2002
  50. ncbi request reprint Images in cardiovascular medicine. Hypertrophic cardiomyopathy in monozygotic twins
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation Minneapolis, Minn 55407, USA
    Circulation 105:2229. 2002
  51. ncbi request reprint The young competitive athlete with cardiovascular abnormalities: causes of sudden death, detection by preparticipation screening, and standards for disqualification
    Barry J Maron
    Cardiovascular Research Division, Minneapolis Heart Institute Foundation, Minneapolis, MN 55407, USA
    Card Electrophysiol Rev 6:100-3. 2002
  52. ncbi request reprint The case for surgery in obstructive hypertrophic cardiomyopathy
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota 55407, USA
    J Am Coll Cardiol 44:2044-53. 2004
    ....
  53. ncbi request reprint Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy
    Barry J Maron
    Minneapolis Heart Institute Foundation, Minneapolis, Minnesota 55407, USA
    J Am Coll Cardiol 39:301-7. 2002
    ..We sought to assess the occurrence and clinical significance of stroke and peripheral arterial embolizations at non-central nervous system sites in a large, community-based cohort with hypertrophic cardiomyopathy (HCM)...
  54. ncbi request reprint Sudden death in young athletes
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, MN 55407, USA
    N Engl J Med 349:1064-75. 2003
  55. ncbi request reprint Clinical course of hypertrophic cardiomyopathy with survival to advanced age
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, 920 E 28th Street, Suite 60, Minneapolis, MN 55407, USA
    J Am Coll Cardiol 42:882-8. 2003
    ..This study was designed to clarify and resolve the clinical profile of older patients with hypertrophic cardiomyopathy (HCM)...
  56. ncbi request reprint Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy
    Barry J Maron
    The Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, 920 E 28th St, Suite 60, Minneapolis, Minn 55407, USA
    Circulation 107:2872-5. 2003
  57. ncbi request reprint Relation of left ventricular thickness to age and gender in hypertrophic cardiomyopathy
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota 55407, USA
    Am J Cardiol 91:1195-8. 2003
    ....
  58. ncbi request reprint Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy
    Barry J Maron
    Minneapolis Heart Institute Foundation, 920 East 28th Street, Suite 60, Minneapolis, MN 55407, USA
    J Am Coll Cardiol 41:974-80. 2003
    ..The goal of this study was to determine the impact of race on identification of hypertrophic cardiomyopathy (HCM)...
  59. ncbi request reprint Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA
    J Am Coll Cardiol 44:2125-32. 2004
    ..Of note, recent developments in laboratory DNA-based diagnosis for HCM could potentially avoid the necessity for serial echocardiography in many such relatives...
  60. ncbi request reprint Usefulness of B-type natriuretic peptide assay in the assessment of symptomatic state in hypertrophic cardiomyopathy
    Barry J Maron
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, and University of Minnesota, Minneapolis, MN 55407, USA
    Circulation 109:984-9. 2004
    ..Plasma B-type natriuretic peptide (BNP) has been used widely as an objective marker for heart failure severity and outcome, predominantly in coronary heart disease with ventricular dilatation and systolic dysfunction...
  61. doi request reprint Global epidemiology and demographics of commotio cordis
    Barry J Maron
    The Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota 55407, USA
    Heart Rhythm 8:1969-71. 2011
    ..However, with enhanced public awareness, commotio cordis has been increasingly recognized internationally as a cause of cardiac arrest and sudden death due to blunt nonpenetrating chest blows...
  62. ncbi request reprint Clinical course of hypertrophic cardiomyopathy in a regional United States cohort
    B J Maron
    Cardiovascular Research Division, Minneapolis Heart Institute Foundation, School of Public Health, University of Minnesota, 55407, USA
    JAMA 281:650-5. 1999
    ..Hypertrophic cardiomyopathy (HCM) has been regarded as a disease that causes substantial disability, with annual mortality rates of up to 6%, based largely on reports from tertiary referral centers...
  63. ncbi request reprint Extended septal myectomy for hypertrophic obstructive cardiomyopathy with anomalous mitral papillary muscles or chordae
    Kenji Minakata
    Division of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn, USA
    J Thorac Cardiovasc Surg 127:481-9. 2004
    ..We reviewed our results of procedures designed to relieve obstruction with preservation of the mitral valve...
  64. ncbi request reprint Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population
    B J Maron
    Minneapolis Heart Institute Foundation, Minneapolis, MN 55407, USA
    Circulation 102:858-64. 2000
    ..These data emanated from tertiary HCM centers with highly selected referral patterns skewed toward high-risk patients...
  65. ncbi request reprint Clinical profile of commotio cordis: an under appreciated cause of sudden death in the young during sports and other activities
    B J Maron
    Minneapolis Heart Institute Foundation, Minnesota 55407, USA
    J Cardiovasc Electrophysiol 10:114-20. 1999
    ....
  66. ncbi request reprint Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabol
    Barry J Maron
    Minneapolis Heart Institute Foundation, USA
    Circulation 115:1643-455. 2007
  67. ncbi request reprint Relation of electrocardiographic patterns to phenotypic expression and clinical outcome in hypertrophic cardiomyopathy
    Julia V Montgomery
    The Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, MN, USA
    Am J Cardiol 96:270-5. 2005
    ..Diverse ECG patterns, consistent with heterogeneous expression of this disease, did not predict HC-related death. Scalar electrocardiography has selective but limited power in routine clinical assessments of patients with HC...
  68. ncbi request reprint Ventricular arrhythmias, sudden death, and prevention in patients with hypertrophic cardiomyopathy
    B J Maron
    Minneapolis Heart Institute Foundation, 920 E 28th Street, Suite 40, Minneapolis, MN 55407, USA
    Curr Cardiol Rep 2:522-8. 2000
    ....
  69. ncbi request reprint Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy
    Uma S Valeti
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA
    J Am Coll Cardiol 49:350-7. 2007
    ..This study sought to describe the acute morphologic differences that result from septal myectomy and alcohol septal ablation using cardiac magnetic resonance (CMR) imaging...
  70. ncbi request reprint Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy
    B J Maron
    Minneapolis Heart Institute Foundation, MN 55407, USA
    N Engl J Med 342:365-73. 2000
    ..Hypertrophic cardiomyopathy is a genetic disease associated with a risk of ventricular tachyarrhythmias and sudden death, especially in young patients...
  71. ncbi request reprint Implications of arrhythmias and prevention of sudden death in hypertrophic cardiomyopathy
    A Selcuk Adabag
    Division of Cardiology, Veterans Affairs Medical Center, Minneapolis, MN 55417, USA
    Ann Noninvasive Electrocardiol 12:171-80. 2007
  72. ncbi request reprint Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy
    A Selcuk Adabag
    Division of Cardiology, and Geriatric Research Education and Clinical Center, Veterans Affairs Medical Center, Minneapolis, Minnesota, USA
    J Am Coll Cardiol 45:697-704. 2005
    ..The goal of this study was to assemble a profile and assess the significance of arrhythmias in a nontertiary-based hypertrophic cardiomyopathy (HCM) cohort...
  73. ncbi request reprint Risk stratification and prevention of sudden death in hypertrophic cardiomyopathy
    Barry J Maron
    Minneapolis Heart Institute Foundation, Minneapolis, Minnesota 55407, USA
    Cardiol Rev 10:173-81. 2002
    ....
  74. ncbi request reprint Acute and reversible cardiomyopathy provoked by stress in women from the United States
    Scott W Sharkey
    Minneapolis Heart Institute Foundation, Minneapolis, Minn 55407, USA
    Circulation 111:472-9. 2005
    ..A clinical entity characterized by acute but rapidly reversible left ventricular (LV) systolic dysfunction and triggered by psychological stress is emerging, with reports largely confined to Japan...
  75. ncbi request reprint Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY)
    B J Maron
    Minneapolis Heart Institute Foundation, Minneapolis, MN 55407, USA
    Circulation 99:2927-33. 1999
    ..Dual-chamber pacing (DDD) has been proposed as a treatment alternative to surgery for severely symptomatic patients with obstructive hypertrophic cardiomyopathy (HCM), based largely on uncontrolled studies...
  76. doi request reprint Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance
    Martin S Maron
    Hypertrophic Cardiomyopathy Center, Division of Cardiology, Tufts Medical Center, Boston, Massachusetts 02111, USA
    J Am Coll Cardiol 54:220-8. 2009
    ....
  77. ncbi request reprint Brief communication: Cardiovascular screening practices of major North American professional sports teams
    Kevin M Harris
    Minneapolis Heart Institute Foundation, Minneapolis, Minnesota 55407, USA
    Ann Intern Med 145:507-11. 2006
    ..Customary preparticipation screening strategies to detect heart disease in professional athletes have not been examined systematically...
  78. ncbi request reprint Significance and relation between magnitude of left ventricular hypertrophy and heart failure symptoms in hypertrophic cardiomyopathy
    Martin S Maron
    Hypertrophic Cardiomyopathy Center, Division of Cardiology, Tufts New England Medical Center, Boston, Massachusetts 02111, USA
    Am J Cardiol 95:1329-33. 2005
    ..In conclusion, no direct relation was evident between symptoms of heart failure and magnitude of LV wall thickness, with implications for the natural history of HC...
  79. ncbi request reprint Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy
    Kevin M Harris
    Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, 920 E 28th St, Suite 60, Minneapolis, Minnesota 55407, USA
    Circulation 114:216-25. 2006
    ..End stage (ES) is a recognized part of the hypertrophic cardiomyopathy (HCM) disease spectrum. Frequency, clinical profile and course, and treatment strategies in these patients remain incompletely defined...
  80. ncbi request reprint Role of family history of sudden death in risk stratification and prevention of sudden death with implantable defibrillators in hypertrophic cardiomyopathy
    J Martijn Bos
    Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA
    Am J Cardiol 106:1481-6. 2010
    ....
  81. ncbi request reprint Identical twins with hypertrophic cardiomyopathy and apical aneurysm
    Andrey G Zenovich
    The Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA
    Am J Cardiol 97:1109. 2006
    ..These cases demonstrate a genetic predisposition to the development of apical aneurysm, as well as overall LV morphology, in patients with HC...
  82. ncbi request reprint Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy
    Carsten Rickers
    Department of Radiology, Fairview University Medical Center, Minneapolis, MN, USA
    Circulation 112:855-61. 2005
    ..The present study was undertaken to determine whether cardiac MRI (CMR) affords greater accuracy than echocardiography in establishing the diagnosis and assessing the magnitude of left ventricular (LV) hypertrophy in HCM...
  83. ncbi request reprint Determinants for clinical diagnosis of hypertrophic cardiomyopathy
    A Selcuk Adabag
    Division of Cardiology, Veterans Affairs Medical Center, Minneapolis, Minnesota, USA
    Am J Cardiol 98:1507-11. 2006
    ..These data underscore the need for heightened awareness and clinical suspicion of HC to increase the number of diagnosed patients, including many who may be at high risk for sudden death...
  84. ncbi request reprint Assessment of QT dispersion as a prognostic marker for sudden death in a regional nonreferred hypertrophic cardiomyopathy cohort
    B J Maron
    Minneapolis Heart Institute Foundation, Minnesota 55407, USA
    Am J Cardiol 87:114-5, A9. 2001
    ..Therefore, QT dispersion would not appear to be useful in devising future risk stratification strategies for predicting sudden death in HC...
  85. doi request reprint Epidemiology of sudden death in young, competitive athletes due to blunt trauma
    Mathew Thomas
    Minneapolis Heart Institute Foundation, 920 E 28th St, Suite 620, Minneapolis, MN 55407, USA
    Pediatrics 128:e1-8. 2011
    ..Sudden deaths of young competitive athletes are highly visible events that have a substantial effect on families and communities. Recent attention has focused predominantly on cardiovascular causes, and less on traumatic organ damage...
  86. ncbi request reprint Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy
    Martin S Maron
    Division of Cardiology, Tufts New England Medical Center, Boston, USA
    N Engl J Med 348:295-303. 2003
    ..The influence of left ventricular outflow tract obstruction on the clinical outcome of hypertrophic cardiomyopathy remains unresolved...
  87. ncbi request reprint Prevalence and clinical significance of left atrial remodeling in competitive athletes
    Antonio Pelliccia
    National Institute of Sports Medicine, Italian National Olympic Committee, Rome, Italy
    J Am Coll Cardiol 46:690-6. 2005
    ....
  88. ncbi request reprint American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European S
    Barry J Maron
    J Am Coll Cardiol 42:1687-713. 2003
  89. ncbi request reprint Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy
    Iacopo Olivotto
    Regional Referral Center for Myocardial Diseases, Azienda Ospedaliera Universitaria Careggi, Florence, Italy
    J Am Coll Cardiol 46:480-7. 2005
    ..The goal of this study was to assess gender-related differences in a multicenter population with hypertrophic cardiomyopathy (HCM)...
  90. ncbi request reprint Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy
    Steve R Ommen
    Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    J Am Coll Cardiol 46:470-6. 2005
    ..This study sought to determine the impact of surgical myectomy on long-term survival in hypertrophic cardiomyopathy (HCM)...
  91. ncbi request reprint Relation between training-induced left ventricular hypertrophy and risk for ventricular tachyarrhythmias in elite athletes
    Alessandro Biffi
    Institute of Sports Medicine and Science, Italian Olympic Committee, Rome, Italy
    Am J Cardiol 101:1792-5. 2008
    ..These data offer a measure of clinical reassurance regarding the benign nature of ventricular tachyarrhythmias in elite athletes and the expression of athlete's heart...
  92. ncbi request reprint Sudden cardiac death caused by innocent chest wall blows
    Mark S Link
    Ital Heart J 6:281-3. 2005
  93. ncbi request reprint Role of streptomycin-sensitive stretch-activated channel in chest wall impact induced sudden death (commotio cordis)
    Arthur R Garan
    New England Cardiac Arrhythmia Center, Tufts New England Medical Center, Boston, Massachusetts, USA
    J Cardiovasc Electrophysiol 16:433-8. 2005
    ..In this study, a nonselective stretch-activated cation channel was pharmacologically blocked prior to chest blows to determine whether this channel represents a possible pathway by which commotio cordis events occur...
  94. ncbi request reprint Glycogen storage diseases presenting as hypertrophic cardiomyopathy
    Michael Arad
    Division of Cardiology, Brigham and Women s Hospital, Boston, USA
    N Engl J Med 352:362-72. 2005
    ....
  95. ncbi request reprint Comparison of prevalence of apical hypertrophic cardiomyopathy in Japan and the United States
    Hiroaki Kitaoka
    Department of Medicine and Geriatrics, Kochi Medical School, Kochi, Japan
    Am J Cardiol 92:1183-6. 2003
    ..Patients with the apical form of HC had a benign clinical course...
  96. ncbi request reprint Remodeling of left ventricular hypertrophy in elite athletes after long-term deconditioning
    Antonio Pelliccia
    Institute of Sports Science, Department of Medicine, Rome, Italy
    Circulation 105:944-9. 2002
    ..The clinical significance and long-term consequences of left ventricular (LV) hypertrophy associated with intensive athletic conditioning remain unresolved...
  97. ncbi request reprint Hypertrophic cardiomyopathy: an important global disease
    Barry J Maron
    Am J Med 116:63-5. 2004
  98. ncbi request reprint Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes
    Alessandro Biffi
    Institute of Sports Science, Department of Medicine, Italian National Olympic Committee, Rome, Italy
    J Am Coll Cardiol 40:446-52. 2002
    ..The aim of this study was to clarify the clinical relevance of ventricular tachyarrhythmias assessed by 24-h ambulatory electrocardiograms (ECG) in a large, unique, and prospectively evaluated athletic population...
  99. doi request reprint Outcomes in athletes with marked ECG repolarization abnormalities
    Antonio Pelliccia
    Institute of Sports Medicine and Science, Italian National Olympic Committee, Rome, Italy
    N Engl J Med 358:152-61. 2008
    ..We assessed long-term clinical outcomes in athletes with ECGs characterized by marked repolarization abnormalities...
  100. pmc Inter-association Task Force recommendations on emergency preparedness and management of sudden cardiac arrest in high school and college athletic programs: a consensus statement
    Jonathan A Drezner
    University of Washington, Seattle, WA 98105, USA
    J Athl Train 42:143-58. 2007
    ..This consensus statement summarizes our current understanding of SCA in young athletes, defines the necessary elements for emergency preparedness, and establishes uniform treatment protocols for the management of SCA...
  101. ncbi request reprint Inter-association task force recommendations on emergency preparedness and management of sudden cardiac arrest in high school and college athletic programs: a consensus statement
    Jonathan A Drezner
    University of Washington, Seattle, WA, USA
    Clin J Sport Med 17:87-103. 2007
    ..This consensus statement summarizes our current understanding of SCA in young athletes, defines the necessary elements for emergency preparedness, and establishes uniform treatment protocols for the management of SCA...